Nobel Prize Winning Cholesterol Researchers Brown and Goldstein Enter Cyclodextrin Field Of Study
November 10, 2009 by Chris Hempel
Filed under Featured Stories
I wonder how many smart cholesterol researchers have Google Alerts set up on Brown and Goldstein Labs? If they do they might want to read this post about the Nobel Prize winning labs release of a very important cholesterol paper involving cyclodextrin and its modulation of cellular cholesterol metabolism. With their amazing new research work, […]
Parents To Seek FDA Orphan Drug Designation For Cyclodextrin To Treat Rare and Fatal Cholesterol Disease
October 10, 2009 by Chris Hempel
Filed under Cyclodextrin, Cyclodextrin News
On Tuesday morning at 11am, Addi and Cassi are going to undergo volumetric CT scans of their livers and spleens. The tests are being conducted by doctors to determine if the cyclodextrin IV infusion treatment the twins are receiving under compassionate use INDs approved by the FDA are reducing the size of their enlarged cholesterol […]
Wall Street Journal Reports on Cyclodextrin, NPC, and HIV-AIDs
July 4, 2009 by Daddy
Filed under Addi and Cassi News, HIV-Aids
Extra TV Renegade Doctors Show Covers FDA Approval of Addi and Cassi’s Cyclodextrin Infusions
June 12, 2009 by Chris Hempel
Filed under Videos
Renegade Doctors (Extra) Story about Addi & Cassi Hempel’s Infusions of Cyclodextrin from Addi & Cassi Hempel on Vimeo. Twins Addison and Cassidy Hempel are fighting a disease that steals their memory, but they’re only five years old. Now their mother Chris is on a crusade to stop Niemann-Pick Disease Type C, a disease similar […]
Anthrax Bacteria Killed By Simple Sugar Compound Called Cyclodextrin. Is CDC Looking Into This?
June 9, 2009 by Chris Hempel
Filed under Cyclodextrin
We all remember the Anthrax-laced letters that killed five people and severely rattled the country post-9/11. Just when you thought there might not be a way to stop this lethal infectious disease along comes beta cyclodextrin, a non toxic sugar compound. A researcher by the name of Vladimir Karginov at a company called Innovative Biologics […]






